In diabetic kidney disease, VEGFC induced lymphangiogenesis in association with fibrosis through transforming growth factor-β (TGFβ) and connective tissue growth factor (CTGF) mediated upregulation of VEGFC expression [43]. This evidence concerns the gene CCN2 and diabetic kidney disease.